![](https://endpts.com/wp-content/uploads/2024/05/David-Urech-Numab-Therapeutics-CEO.jpg)
David Urech, Numab Therapeutics CEO
J&J makes another I&I acquisition with $1.25B deal for Numab's Yellow Jersey
Johnson & Johnson is spending $1.25 billion in cash to buy Yellow Jersey Therapeutics, marking its second acquisition …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.